New bromophenol derivatives as specific PTP1B inhibitors for the treatment of type 2 diabetes April 10, 2019
BAY-218, a first-in-class AhR antagonist for overcoming tumor-mediated immunosuppression April 10, 2019
Phase I trial assesses iC9.GD2.CAR.IL-15 T cells in pediatric relapsed or refractory neuroblastoma April 9, 2019
RSS